Search Results - "YEE, Y. K."

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second‐line treatment of resistant Helicobacter pylori infection by WONG, W. M., GU, Q., CHU, K.‐M., YEE, Y. K., FUNG, F. M. Y., TONG, T. S. M., CHAN, A. O. O., LAI, K. C., CHAN, C. K., WONG, B. C. Y.

“…Summary Aim To test the efficacy of levofloxacin‐based second‐line therapy for resistant Helicobacter pylori infection. Methods One hundred and six patients…”
Get full text

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection by Wong, W. M., Gu, Q., Lam, S. K., Fung, F. M. Y., Lai, K. C., Hu, W. H. C., Yee, Y. K., Chan, C. K., Xia, H. H. X., Yuen, M. F., Wong, B. C. Y.

“…Summary Aim : To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second‐line treatment of…”
Get full text

Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection by YEE, Y. K., CHEUNG, T. K., CHU, K.‐M., CHAN, C. K., FUNG, J., CHAN, P., BUT, D., HUNG, I., CHAN, A. O. O., YUEN, M. F., HSU, A., WONG, B. C. Y.

“…Summary Background  The efficacy of levofloxacin‐based quadruple therapy in resistant Helicobacter pylori infection is not known. Aim  To test the efficacy of…”
Get full text

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients by Wong, W M, Wong, B C Y, Hung, W K, Yee, Y K, Yip, A W C, Szeto, M L, Fung, F M Y, Tong, T S M, Lai, K C, Hu, W H C, Yuen, M F, Lam, S K

“…Background: The use of proton pump inhibitors for the treatment of functional dyspepsia is controversial and the role of Helicobacter pylori infection in…”
Get full text

Rabeprazole‐based 3‐day and 7‐day triple therapy vs. omeprazole‐based 7‐day triple therapy for the treatment of Helicobacter pylori infection by Wong, B. C. Y., Wong, W. M., Yee, Y. K., Hung, W. K., Yip, A. W. C., Szeto, M. L., Li, K. F., Lau, P., Fung, F. M. Y., Tong, T. S. M., Lai, K. C., Hu, W. H. C., Yuen, M. F., Hui, C. K., Lam, S. K.

“…Background: Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti‐Helicobacter effects. Aim: To compare two different regimens…”
Get full text

Efficacy of enzyme immunoassay for the detection of Helicobacter pylori antigens in frozen stool specimens: local validation by Yee, Y. K., Yip, K. T., Que, T. L., Chang, K. K., Li, K. F., Lee, C. K., Wong, S. W., Lau, S. F., Szeto, M.L.

“…Summary Aim : To investigate the efficacy of measurement of Helicobacter pylori stool antigen (HpSA) using stored frozen stool specimens, and to assess whether…”
Get full text

Anti‐Helicobacter pylori activity of Chinese tea: in vitro study by Yee, Yuk‐Kei, Koo, Marcel Wing‐Leung

“…Background: Chinese tea has an antibacterial activity against a wide range of bacteria. However, its activity against Helicobacter pylori has not been…”
Get full text

Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese by Szeto, M. L., Lee, C. K., Yee, Y. K., Li, K. F., Lee, W. K., Lee, C. C., Que, T. L., Wong, B. C. Y.

“…Background: Commercial serological tests for the detection of Helicobacter pylori infection must be locally validated. We evaluated the accuracy of five…”
Get full text

Non-Amidine-Containing 1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa with Potent Anticoagulant and Antithrombotic Activity by Masters, John J, Franciskovich, Jeffry B, Tinsley, Jennifer M, Campbell, Charles, Campbell, Jack B, Craft, Trelia J, Froelich, Larry L, Gifford-Moore, Donetta S, Hay, Lynne A, Herron, David K, Klimkowski, Valentine J, Kurz, Kenneth D, Metz, James T, Ratz, Andrew M, Shuman, Robert T, Smith, Gerald F, Smith, Tommy, Towner, Richard D, Wiley, Michael R, Wilson, Alex, Yee, Ying K

Get full text

In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist by Snyder, D W, Giles, R E, Keith, R A, Yee, Y K, Krell, R D

“…ICI 198,615 is a representative compound from a new class of peptide leukotriene (LT) receptor antagonists. In isolated guinea pig trachea and parenchymal lung…”
Get more information

Unusual overlap of systemic lupus erythematosus and diffuse scleroderma by Mok, C C, Cheung, J C, Yee, Y K, Szeto, M L

Get full text

Strongyloidiasis as a possible cause of nephrotic syndrome by Yee, Yuk-kei, Lam, Cheuk-sum, Yung, Chun-yu, Que, Tak-lun, Kwan, Tze-hoi, Au, Tak-cheung, Szeto, Ming-leung

“…Chronic strongyloidiasis is a mild disease and has never been reported to be associated with nephrotic syndrome. Disseminated strongyloidiasis is known to have…”
Get full text

Effect of annealing on the magnetic properties and performance of cold-drawn micro Ni80Fe20/Cu wires in magnetic sensors by Seet, H L, Li, X P, Lee, K S, Yee, K Y, Liang, L Q, Yi, J B

Get full text

A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles by Yee, Ying K, Bernstein, Peter R, Adams, Edward J, Brown, Frederick J, Cronk, Laura A, Hebbel, Kevin C, Vacek, Edward P, Krell, Robert D, Snyder, David W

“…A systematic structure-activity exploration of the carboxylic acid region in a series of indole- or indazole-derived leukotriene antagonists 1 led to several…”
Get full text

In vivo pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist by Krell, R D, Giles, R E, Yee, Y K, Snyder, D W

“…The in vivo pharmacology of ICI 198,615, a highly potent and selective peptide leukotriene (LT) receptor antagonist, is described. In a conscious guinea pig…”
Get more information

Autonomous Deep Quality Monitoring in Streaming Environments by Ashfahani, Andri, Pratama, Mahardhika, Lughofer, Edwin, Yee, E. Y. K.

“…The common practice of quality monitoring in industry relies on manual inspection well-known to be slow, error-prone and operator-dependent. This issue raises…”
Get full text

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist by Krell, R D, Aharony, D, Buckner, C K, Keith, R A, Kusner, E J, Snyder, D W, Bernstein, P R, Matassa, V G, Yee, Y K, Brown, F J

“…ICI 204,219 (4-(5-cyclopentyloxycarbonylamino-1-methylindol-3-ylmethy l)-3- methoxy-N-o-tolylsulfonylbenzamide) was designed as a peptide leukotriene (LT)…”
Get more information

1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa by Herron, David K, Goodson, Theodore, Wiley, Michael R, Weir, Leonard C, Kyle, Jeffrey A, Yee, Ying K, Tebbe, Ann Louise, Tinsley, Jennifer M, Mendel, David, Masters, John J, Franciskovich, Jeffry B, Sawyer, J. Scott, Beight, Douglas W, Ratz, Andrew M, Milot, Guy, Hall, Steven E, Klimkowski, Valentine J, Wikel, James H, Eastwood, Brian J, Towner, Richard D, Gifford-Moore, Donetta S, Craft, Trelia J, Smith, Gerald F

“…High-throughput screening of a combinatorial library of diamidophenols yielded lead compounds with the ability to inhibit human factor Xa (fXa) at micromolar…”
Get full text

The force-restore method revisited by YEE, S. Y. K

“…The force-restore method has been used with considerable success in numerical weather prediction models to simulate diurnal variations of ground temperature…”
Get full text

Vertebral artery dissection: a treatable cause of ischaemic stroke by Lam, CS, Yee, YK, Tsui, YK, Szeto, ML

“…Vertebral artery dissection used to be an uncommon diagnosis but it is now being diagnosed more frequently owing to the use of magnetic resonance imaging. We…”
Get full text